Scientists in the UK and Switzerland have identified a signalling pathway, PI3K (phosphoinositide 3-kinase) that shows promise as a target for treating aggressive skin cancer. Their results, based on a study of the see-through zebrafish, are published in the journal Disease Models and Mechanisms.
New zebrafish model offers new insights into skin cancer
Posted by PharmaNewsEU 440 days ago (http://www.pharmanews.eu)Who Voted for this Story
Comments